SEC Comment Letter for Brighthouse Financial, (BHF) — Jun 13, 2017
Brighthouse Financial, Inc.
Date: June 13, 2017 · CIK: 0001685040 · Accession: 0000000000-17-020708
AI Filing Summary & Sentiment
File numbers found in text: 001-37905
Show Raw Text
Mail Stop 4546 June 13 , 201 7 Anant Bhalla Chief Financial Officer Brighthouse Financial, Inc . Gragg Building 11225 North Community House Road Charlotte, NC 28277 Re: Brighthouse Financial , Inc. Amendment No. 3 to Form 10-12B Filed June 2 , 2017 File No. 001-37905 Dear Mr. Bhalla : We have reviewed your amended filing an d have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten busine ss days by providing the requested information or advis e us as soon as possible when you will respond. If you do not believe our comments apply to your facts and ci rcumstances, please tell us why in your response. After reviewing your response and any amendment you may file in response to these comments , we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our May 15, 2017 letter . Exhibit 99.1 – Information Statement Forward -Looking Statements 1. Please note that the safe harbor for forward -looking statements provided by the Private Securities Litigation Reform Act of 1995 (PSLRA) applies to issuers that ar e subject to the reporting requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 at the time the statements are made. P lease revise to remove the implication that the statements in both letters to shareholders are within the protection of the PSLRA or tell us why you believe that the safe harbor is available to you . Anant Bhalla Brighthouse Financial , Inc. June 13 , 201 7 Page 2 MetLife U.S. Retail Separation Business Notes to Combined Financial Statements 1. Business, Basis of Presentation and Summary of Significant Accounting Policies Stock -Based Compensation, page F -32 2. We note your response to revised comment 6, as provided to you by the staff on a call on May 23, 2017, and the revised disclosures in the filing. Regarding stock -compensation expense, please tell us the expected impact on your financial statements upon the separation and, if material, quantify in the notes to the pro forma information and elsewhere as appropriate pursuant to Rule 11 -02(b)(5) of Regulation S -X. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Bonnie Bayne s at (202) 551 -4924 or Sharon Blume at (202) 551 -3474 if you have questions regarding comments on the financial statements and related matters. Please contact Ada D. Sarmento at (202) 551 -3798 or me at (202) 551 -3675 with any other questions. Sincerely, /s/ Suzanne Hayes Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Benjamin Nixon Willkie Farr & Gallagher LLP